Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0242379 (
lung cancer
)
71,905
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Inconsistent association of
microsomal epoxide hydrolase
(
mEH
) polymorphisms (Tyr113His, His139Arg) and
lung cancer
susceptibility have been reported in earlier studies. This study was undertaken to assess if
mEH
Tyr113His and His139Arg represent risk factors for
lung cancer
in Asian population. We exhaustively searched multiple databases to identify all eligible studies. Odds ratios were calculated to estimate the strength of genetic associations. This meta-analysis finally combined 2,522 subjects for Tyr113His and 2,725 subjects for His139Arg. In the analysis of Tyr113His, the His/His genotype carriers were found to have 29 % higher risk of
lung cancer
compared to the Tyr/Tyr carriers (His/His vs. Tyr/Tyr, odds ratio, 1.29, 95 % confidence interval, 1.06-1.58). A significantly increased risk was also seen in His/His versus His/Tyr + Tyr/Tyr (odds ratio, 1.29, 95 % confidence interval, 1.07-1.55). Likewise, His139Arg demonstrated a significant association with
lung cancer
(Arg/His vs. His/His, odds ratio, 1.2 6, 95 % confidence interval, 1.06-1.49; odds ratio, 1.24, 95 % confidence interval, 1.05-1.46). Stratified analysis by ethnicity showed both of the polymorphisms were associated with
lung cancer
in Chinese populations. These results suggest that the genetic associations exist between
mEH
polymorphisms and
lung cancer
susceptibility in Asian populations.
...
PMID:Impact of epoxide hydrolase 1 polymorphisms on lung cancer susceptibility in Asian populations. 2531 77
<< Previous
1
2
3
4